Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer (GELATO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03147040
Recruitment Status : Recruiting
First Posted : May 10, 2017
Last Update Posted : January 22, 2021
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by (Responsible Party):
The Netherlands Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 1, 2022
Estimated Study Completion Date : July 1, 2029